Quell Therapeutics is based in London, United Kingdom. It has raised $344M in total funding. Latest round: Series B.
Quell Therapeutics is based in London, United Kingdom. Quell Therapeutics has raised $344M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in November 2021. The round record for Quell Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Syncona, UCL Technology Fund, Fidelity Management & Research Company, Ridgeback Capital, Jeito Capital, SV Health Investors and 3 others. 9 distinct backers are named across the disclosed rounds.
Every Quell Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in London at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026